NCI at AACR COVID-19 and Cancer Virtual Meeting

The National Cancer Institute (NCI) is participating in the American Association for Cancer Research (AACR) COVID-19 and Cancer Virtual Meeting , July 20-22, 2020.

The AACR COVID-19 and Cancer Meeting will share the emerging data in basic, clinical, and epidemiologic research related to COVID-19 and cancer. The program features presentations from NCI leaders and experts. These presentations will cover COVID-19 treatment candidates, diagnostics development, cancer drug repurposing, clinical trial changes during the pandemic, and NCI’s role in ensuring cancer research progress. Registration is now available.

Subscribe for the latest information on presentations and resources from NCI at AACR 2020 and future meetings.

NCI Director

NCI Director, Norman E. Sharpless, M.D.

Closing Roundtable Session: Returning to Cancer Research During COVID-19
Presentation: NCI's role in ensuring cancer research progress amid a pandemic

Wednesday, July 22, 4:35-6:00 p.m. (EDT)

Additional Presentations Featuring NCI Leaders and Experts

Douglas R. Lowy, M.D.

Symposium 8:COVID-19 Diagnostics Development
Session: When cancer research goes viral

Tuesday, July 21, 2:20-4:20 p.m. (EDT)

James H. Doroshow, M.D.

Forum on Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19

Monday, July 20, 1:05-2:05 p.m. (EDT)

Louis M. Staudt, Ph.D.

Symposium 4: Cancer Drug Repurposing to Treat COVID-19
Session: Inhibition of Bruton Tyrosine Kinase in patients with severe COVID-19

Monday, July 20, 2:20-4:35 p.m. (EDT)

Funding Notices for COVID-19

NCI is providing funding for research on COVID-19 and revising some existing grants and cooperative agreements to make funds available to help address the public health crisis. For more information, see NCI Funding Announcements and Notices for COVID-19.